Abbott Laboratories (XSWX:ABT) Non Operating Income: CHF491 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:ABT Abbott Laboratories XSWX:ABT
80 GF Score
Price CHF84.50
GF Value CHF107.34
View Full Analysis

What is Abbott Laboratories Non Operating Income?

Abbott Laboratories XSWX:ABT +2.42% 80 Non Operating Income is CHF491 Mil as of Mar. 2026. GuruFocus rates XSWX:ABT with a GF Score™ of 80/100 and a GF Value™ of CHF107.34.

Non Operating Income is income or expense that comes from miscellaneous sources. Abbott Laboratories's Non Operating Income for the three months ended in Mar. 2026 was CHF135 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was CHF491 Mil.

Abbott Laboratories Non Operating Income Related Terms

Abbott Laboratories Non Operating Income Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories Non Operating Income Chart

Abbott Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Non Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 254.20 297.18 378.78 359.32 476.55

Abbott Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 120.35 132.95 118.74 135.42 103.91
XSWX:ABT
80GF Score
Abbott Laboratories XSWX:ABT
Non Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF491 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Non Operating Income →
What does a Non Operating Income of CHF491 Mil mean?
Abbott Laboratories (XSWX:ABT) has a Non Operating Income of CHF491 Mil as of Mar. 2026. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Abbott Laboratories and its competitors.
Is Abbott Laboratories' Non Operating Income too high?
Abbott Laboratories' current Non Operating Income is CHF491 Mil. Overall, Abbott Laboratories has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Non Operating Income compare to SYK and MDT?
Abbott Laboratories' Non Operating Income of CHF491 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Non Operating Income for a Medical Devices & Instruments company?
A good Non Operating Income depends on the Medical Devices & Instruments industry context. However, Non Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Non Operating Income mean?
A high Non Operating Income can signal that a stock is expensive relative to its fundamentals. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Abbott Laboratories and its competitors. Abbott Laboratories's current Non Operating Income is CHF491 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Abbott Laboratories (XSWX:ABT) has a current Non Operating Income of CHF491 Mil. The stock's GF Value™ is CHF107.34, compared to a current price of CHF84.50 — trading 21.3% below its estimated fair value. The current Non Operating Income is CHF491 Mil. Abbott Laboratories' overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Non Operating Income calculated?
Non Operating Income is calculated from a company's financial statements. For Abbott Laboratories (XSWX:ABT), the current Non Operating Income is CHF491 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (XSWX:ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of CHF84.50 is trading 21.3% below its estimated GF Value™ of CHF107.34.

Key valuation signals for XSWX:ABT:

  • Non Operating Income: CHF491 Mil
  • GF Value™: CHF107.34 vs. price of CHF84.50 (21.3% below fair value)
  • GF Score™: 80/100

No single metric tells the full story. See the XSWX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score

Get the complete analysis for XSWX:ABT

Non Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF84.50
Price
CHF107.34
GF Value